Utility of the estimated glucose disposal rate as a marker of microvascular complications in young adults with type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 96, Issue 3, 2012, Pages

  Girgis, Christian M ^a   Scalley, Benjamin D ^a   Park, Kris E J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Complications; Estimated glucose disposal rate; Insulin resistance; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT TOOL; CROSS-SECTIONAL STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE MARKER; ESTIMATED GLUCOSE DISPERSAL RATE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; WAIST HIP RATIO;

ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; RISK FACTORS; YOUNG ADULT;

EID: 84862234401     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.02.004     Document Type: Article

References (11)

1. Makimattila S., Virkamaki A., Malmstrom R., Utriainen T., Yki-Jarvinen H. Insulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction. J Clin Endocrinol Metab 1996, 81:707-712.
2. Orchard T.J., Olson J.C., Erbey J.R., Williams K., Forrest K.Y.-Z., Smithline Kinder L., et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes. Diabetes Care 2003, 26:1374-1379.
3. Makinen V.-P., Forsblom C., Thorn L.M., Wadén J., Gordin D., Heikkilä O., et al. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4197 patients with type I diabetes. Diabetes 2008, 57:2480-2487.
4. Chaturvedi N., Sjoelie A.-K., Porta M., Aldington S.J., Fuller J.H., Songini M., et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001, 24:284-289.
5. Pang T.T.L., Narendran P. Addressing insulin resistance in type 1 diabetes. Diabet Med 2008, 25:1015-1024.
6. Reinehr T., Holl R.W., Roth C.L., Wiesel T., Stachow R., Wabitsch M., et al. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatr Diab 2005, 6:5-12.
7. Williams K.V., Erbey J.R., Becker D., Arslanian S., Orchard T.J. Can clinical factors estimate insulin resistance in type I diabetes?. Diabetes 2000, 49:626-632.
8. Pambianco G., Costacou T., Orchard T.J. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. Diabetes Care 2007, 30:1248-1254.
9. Wan Nazaimoon W.M., Letchuman R., Noraini N., Ropilah A.R., Zainal M., Ismail I.S., et al. Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics. Diabetes Res Clin Pract 1999, 46:213-221.
10. Rodrigues T.C., Canani L.H., Schvartzman P., Gross J.L. Hypertension is the metabolic syndrome component most strongly associated with microvascular complications and coronary artery calcification in type 1 diabetes. J Endocrinol Invest 2011, 34(3):e58-e63.
11. Nørgaard K., Feldt-Rasmussen B., Deckert T. Is hypertension a major independent risk factor for retinopathy in type 1 diabetes?. Diabet Med 1991, 8:334-337.